Investigation of the role ofMMP3 -1171insApolymorphism in cutaneous malignant melanoma – a preliminary study

The role of EMMPRIN expression in ovarian epithelial carcinomas

(2013) Yang Zhao et al.   CELL CYCLE

Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: A meta-analysis

(2013) Chaoliang Hu et al.   GENE

Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis

(2013) Xiaoying Li et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Meta-Analysis of MMP2, MMP3, and MMP9 Promoter Polymorphisms and Head and Neck Cancer Risk

(2013) Caiyun Zhang et al.   PLoS One

Genetic polymorphisms in MMP 2, 9 and 3genes modify lung cancer risk and survival

(2012) Patricia González-Arriaga et al.   BMC CANCER

Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target

(2010) Eleonore Fröhlich   CELLULAR AND MOLECULAR LIFE SCIENCES

The Genotypes of IL-1 beta and MMP-3 are Associated with the Prognosis of HCV-related Hepatocellular Carcinoma

(2010) Kinya Okamoto et al.   INTERNAL MEDICINE

Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models

(2009) Miriam Fanjul-Fernández et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma

(2008) Faruk Tas et al.   MEDICAL ONCOLOGY

The regulation of matrix metalloproteinases and their inhibitors

(2007) I CLARK et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY